First Abu Dhabi Bank EMTN US$20b Fourth Supplement

Summary by AI ^BETAClose X

First Abu Dhabi Bank P.J.S.C. has issued a fourth supplement to its base prospectus dated 10 July 2025, concerning its Euro Medium Term Note Programme. This supplement, dated 29 April 2026, forms part of the original prospectus and relates to the issuance of notes with an aggregate nominal amount of up to U.S.$20,000,000,000. The supplement and the base prospectus are available on the bank's investor relations website.

Disclaimer*

First Abu Dhabi Bank P.J.S.C.

29 April 2026

First Abu Dhabi Bank P.J.S.C.

Fourth Supplement dated 29 April 2026 to the Base Prospectus dated 10 July 2025

29 April 2026

This base prospectus supplement (the "Supplement") is supplemental to, forms part of and must be read and construed in conjunction with, the base prospectus dated 10 July 2025 (the "Base Prospectus") prepared by First Abu Dhabi Bank PJSC (the "Issuer", "FAB" or the "Bank") in connection with the Issuer's Euro Medium Term Note Programme (the "Programme") for the issuance of up to U.S.$20,000,000,000 in aggregate nominal amount of notes (the "Notes"). Terms defined in the Base Prospectus shall, unless the context otherwise requires, have the same meaning when used in this Supplement.

The Supplement along with the Base Prospectus will also be available FAB's IR website.

http://www.rns-pdf.londonstockexchange.com/rns/4294C_1-2026-4-29.pdf

For more information, please visit https://www.bankfab.com/or FAB Investor Relations.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.

END